Ajou University repository

  • Results/Page
  • Sort by
  • In order
  • Authors/record

Showing results 1 to 10 of 20459 (Search time: 0.0 seconds).

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infectionoa mark
  • Farooq, Mariya;
  • Khan, Abdul Waheed;
  • Ahmad, Bilal;
  • Kim, Moon Suk;
  • Choi, Sangdun
  • 2022-06-30
  • Frontiers in Pharmacology, Vol.13
  • Frontiers Media S.A.
Ultra-fast and recyclable DNA biosensor for point-of-care detection of SARS-CoV-2 (COVID-19)oa mark
  • Hwang, Chuljin;
  • Park, Nakkyun;
  • Kim, Eun Seong;
  • Kim, Miran;
  • Kim, Su Dong;
  • Park, Sungjun;
  • Kim, Nam Young;
  • Kim, Joo Hee
  • 2021-08-01
  • Biosensors and Bioelectronics, Vol.185
  • Elsevier Ltd
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs
  • Lee, Jisun;
  • Kim, Bomi;
  • Woo, Hye Min;
  • Kim, Jun Won;
  • Jung, Inji;
  • Park, Seong Wook;
  • Kim, Yong Sung;
  • Na, Jung Hyun;
  • Jung, Sang Taek
  • 2024-09-02
  • Molecular Pharmaceutics, Vol.21, pp.4336-4346
  • American Chemical Society
Remdesivir and ledipasvir among the fda-approved antiviral drugs have potential to inhibit sars-cov-2 replicationoa mark
  • Pirzada, Rameez Hassan;
  • Haseeb, Muhammad;
  • Batool, Maria;
  • Kim, Moonsuk;
  • Choi, Sangdun
  • 2021-05-01
  • Cells, Vol.10
  • MDPI
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapyoa mark
  • Jung, Keunok;
  • Ko, Deok Han;
  • Jang, Jeong Yun;
  • Kim, Young Rong;
  • Heo, Jung Yeon;
  • Kim, Yong Sung
  • 2024-01-01
  • Cancer Communications, Vol.44, pp.173-177
  • John Wiley and Sons Inc
Exploring the binding mechanism of PF-07321332 SARS-CoV-2 protease inhibitor through molecular dynamics and binding free energy simulationsoa mark
  • Ahmad, Bilal;
  • Batool, Maria;
  • Ain, Qurat Ul;
  • Kim, Moon Suk;
  • Choi, Sangdun
  • 2021-09-01
  • International Journal of Molecular Sciences, Vol.22
  • MDPI
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variantsoa mark
  • Lee, Sua;
  • Jang, Shina;
  • Kang, Jihoon;
  • Park, Soo Bin;
  • Han, Young Woo;
  • Nam, Hyemi;
  • Kim, Munkyung;
  • Lee, Jeewon;
  • Cho, Ki Joon;
  • Kim, Jeonghun;
  • Oh, Miyoung;
  • Ryu, Jihye;
  • Seok, Jong Hyeon;
  • Kim, Yunhwa;
  • Lee, Jee Boong;
  • Park, Man Seong;
  • Kim, Yong Sung;
  • Park, Hosun;
  • Kim, Dong Sik
  • 2021-11-18
  • Frontiers in Immunology, Vol.12
  • Frontiers Media S.A.
Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS-CoV-2 Variants
  • Hwang, Jaehyeon;
  • Kim, Beom Kyu;
  • Moon, Seokoh;
  • Park, Wonbeom;
  • Kim, Kyeong Won;
  • Yoon, Jeong Hyeon;
  • Oh, Hyunseok;
  • Jung, Sangwon;
  • Park, Youngseo;
  • Kim, Suhyun;
  • Kim, Misoo;
  • Kim, Soomin;
  • Jung, Younghun;
  • Park, Myungseo;
  • Kim, Jun Ho;
  • Jung, Sang Taek;
  • Kim, Sang Jick;
  • Kim, Yong Sung;
  • Chung, Woo Jae;
  • Song, Min Suk;
  • Kweon, Dae Hyuk
  • 2024-06-01
  • Advanced Healthcare Materials, Vol.13
  • John Wiley and Sons Inc
1 2 3 4 2046